Related Experiment Video

Updated: Mar 17, 2026

An Orthotopic Murine Model of Human Prostate Cancer Metastasis
06:48

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

Published on: September 18, 2013

36.0K

IKK inhibitor suppresses epithelial-mesenchymal transition and induces cell death in prostate cancer

Hao Ping1, Feiya Yang1, Mingshuai Wang1

  • 1Department of Urology, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, P.R. China.

Oncology Reports
|July 20, 2016
PubMed

Insights

This study shows that inhibiting the IκB kinase (IKK) pathway with BMS-345541 reduces prostate cancer cell growth and metastasis. The IKK inhibitor effectively reversed epithelial-mesenchymal transition (EMT) and induced apoptosis in cancer cells.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • The IκB kinase (IKK)/nuclear factor κB (NF-κB) pathway is crucial for prostate cancer's invasive and metastatic potential.
  • Activation of this pathway promotes tumor progression and resistance to apoptosis.

Purpose of the Study:

  • To investigate the effects of a selective IKK inhibitor, BMS-345541, on epithelial-mesenchymal transition (EMT), apoptosis, and metastasis in prostate cancer cells.
  • To evaluate BMS-345541's potential as a therapeutic target for prostate cancer.

Main Methods:

  • Treatment of PC-3 prostate cancer cells with the IKK inhibitor BMS-345541.
  • Assessment of cell proliferation, apoptosis, and protein expression levels (IκBα, NF-κB/p65, N-cadherin, Snail, Slug, Twist, E-cadherin, p-NDRG1).
  • Evaluation of cell invasion and metastasis using in vitro models.

Main Results:

  • BMS-345541 significantly reduced proliferation and induced apoptosis in PC-3 cells.
  • The inhibitor decreased IκBα phosphorylation and nuclear NF-κB/p65 levels.
  • Downregulation of EMT markers (N-cadherin, Snail, Slug, Twist) and upregulation of the epithelial marker E-cadherin were observed.
  • BMS-345541 treatment led to increased phosphorylated NDRG1 and reduced cancer cell invasion and metastasis in vitro.

Conclusions:

  • The IKK pathway plays a critical role in prostate cancer EMT and apoptosis.
  • IKK inhibition by BMS-345541 effectively reverses EMT, induces cell death, and inhibits metastasis in prostate cancer cells.
  • IKK represents a promising therapeutic target for prostate cancer treatment.

More Related Videos

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

14.7K
Induction and Analysis of Epithelial to Mesenchymal Transition10:37

Induction and Analysis of Epithelial to Mesenchymal Transition

Published on: August 27, 2013

36.7K

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

5.6K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.3K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.7K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
8.2K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.1K